CVS Health Options Spot-On: On May 31st, 132.68K Contracts Were Traded, With 689.34K Open Interest
On May 31st ET, $CVS Health(CVS.US)$ had active options trading, with a total trading volume of 132.68K options for the day, of which put options accounted for 23.05% of the total transactions, and ca
Express News | NYSE Order Imbalance 910198.0 Shares on Buy Side
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities.Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scan
CVS Health's Options Frenzy: What You Need to Know
Deep-pocketed investors have adopted a bullish approach towards CVS Health (NYSE:CVS), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled t
Investors Punished Salesforce After Earnings. See the Other Worst Recent Post-report Reactions
Is Trending Stock CVS Health Corporation (CVS) a Buy Now?
CVS Health Options Spot-On: On May 30th, 89,558 Contracts Were Traded, With 688.02K Open Interest
On May 30th ET, $CVS Health(CVS.US)$ had active options trading, with a total trading volume of 89,558 options for the day, of which put options accounted for 58.74% of the total transactions, and cal
Check Out What Whales Are Doing With CVS
Financial giants have made a conspicuous bullish move on CVS Health. Our analysis of options history for CVS Health (NYSE:CVS) revealed 20 unusual trades.Delving into the details, we found 40% of trad
Express News | NYSE Order Imbalance 134698.0 Shares on Sell Side
CVS on Pace for Largest Percent Increase Since August 2022 -- Data Talk
CVS Health Corporation (CVS) is currently at $56.08, up $2.41 or 4.48% --Would be highest close since May 22, 2024, when it closed at $57.44 --On pace for largest percent increase since Aug. 3, 2022
CVS Health Is Maintained at Overweight by JP Morgan
CVS Health Is Maintained at Overweight by JP Morgan
JP Morgan Maintains Overweight on CVS Health, Lowers Price Target to $86
JP Morgan analyst Lisa Gill maintains CVS Health (NYSE:CVS) with a Overweight and lowers the price target from $101 to $86.
EPharmacy Industry Report 2024-2034 | World Market to Grow by Over $487 Billion at a 20.45% CAGR | Strategic Analysis of Netmeds, CVS Health, Walmart, Walgreen Co, The Kroger Co, and More
What Analysts Are Saying About CVS Health Stock
CVS Health (NYSE:CVS) underwent analysis by 17 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.In the table below, you'll find a summary of their recent rating
JPMorgan Adjusts Price Target on CVS Health to $86 From $101
CVS Health (CVS) has an average outperform rating and a price target range of $59 to $93.31, according to analysts polled by Capital IQ. Price: 53.60, Change: -0.07, Percent Change: -0.13
CVS Health (CVS) Receives a Hold From Wells Fargo
Express News | Baird Initiates Coverage On CVS Health With Neutral Rating, Announces Price Target of $61
CVS Health Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/30/2024 13.83% Baird → $61 Initiates Coverage On → Neutral 05/08/2024 49.28% Argus Research $100 → $80
Express News | CVS Health Corp : JP Morgan Cuts Target Price to $86 From $101
CVS Health Corporation (CVS) Bernstein's 40th Annual Strategic Decisions Conference
CVS Health Corporation (CVS) Bernstein's 40th Annual Strategic Decisions Conference
No Data